Why the study?
Rehabilitation is essential for heart failure management, but its efficacy and cost-effectiveness for patients with acute heart failure remain unclear.
Is acute cardiac rehabilitation cost-effective in older patients with acute heart failure?
Is acute cardiac rehabilitation cost-effective in older patients with acute heart failure?
This paper discusses strategies for evaluating the cost-effectiveness of acute cardiac rehabilitation in older patients with acute heart failure.
Acute cardiac rehabilitation cost-effectiveness in older HF patients remains uncertain; leaves open need for randomized economic trials before practice change.
The prevalence of heart failure (HF) is increasing in the ageing world population, and its burden on the medical and health economic fields is enormous. Rehabilitation is an essential component of the nonpharmacological treatment of patients with HF; however, its efficacy and cost-effectiveness for patients with acute HF remain unclear. A trial assessed the cost-effectiveness of acute cardiac rehabilitation among older adults. Herein, we discussed strategies for the cost-effectiveness analysis of acute cardiac rehabilitation using the rehabilitation therapy in older acute heart failure patients trial.
No takes yet. Share an insight, caveat, or question.
Sakai et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: